The question has been looming around the masses ever since the deadly virus taking the lives of the civilians across the world. We presently have 130 vaccines under testing, across different countries. However, the vaccine trials in India is expected to end by the beginning of 2021, in the first quarter.
Countries like USA, Russia, China and the UK are in the verse of testing those vaccines against COVID 19. India is nevertheless, also in developing the vaccine stage by stage.
The experts claim that they would launch the vaccine against COVID 19 in August. However, the State Medical University of Moscow has stated that successful clinical trials are completed. It started on June 8th, batch by batch they’re discharging.
According to the news conveyed, they are in the second stage of vaccine development. Australian companies, on the other hand, are still riveting in the first stage.
The United States Of America
Further information clears the air as the trials are being conducted at 87 places in the US, wherein the US government is vouching for the development of the vaccine.
They are second in leading the vaccine development race as Oxford University and Imperial College are in the second and third stage of human trials. Stage 2 has already be accounted to 105 and are required to administer the vaccine.
Stage 3 will begin in November 2020 and will cover relatively 6000 people.
Chinese company Sinovac Biotech has reached the third stage, as the reports say. This is the first-ever vaccine against COVID 19 to reach the human species. However, the first dose had 15,000 people volunteering in Abu Dhabi.
The administration of the vaccine within 28 days has set a record on the development of anti-bodies in them. Relatively, there are 4 vaccines under development in China.
Covaxin and ZyCov-D, are the two medicines that are taking phase by phase progress with the vaccine development. India will start the stage 1 and stage 2 trials i.e. human trials in September.
Though Covaxin has been developed by Bharat Biotech i.e. a pharmaceutical company has come forth with a ZyCov-D medicine from Hyderabad. There have been no side effects on the volunteers who have been administered the vaccine.
The production will take force once the trials are completed in March.
The challenges of development:
With the available preliminary data, the median time for clinical recovery for mild cases is approximately 2 weeks and is 3-6 weeks for patient’s critical disease. We all must be aware that when the disease is new, there is no particular vaccine that is developed. It can take several years for a new vaccine to be developed. The human trials are starting in September, in India.
To aid the process, we civilians have to discipline ourselves and abide by the norms to fight COVID 19.